Stay updated on Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page has updated its date references, removing older dates and adding new ones for June 2025.SummaryDifference0.6%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1.0%
- Check26 days agoNo Change Detected
- Check47 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check61 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed information about a phase II trial for nivolumab and BMS986205 in treating head and neck squamous cell carcinoma, while adding new collaborators and a revision number.SummaryDifference40%
- Check69 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 4, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.3%
Stay in the know with updates to Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and BMS986205 in Head&Neck Cancer Clinical Trial page.